Literature DB >> 17431678

Arginine-vasopressin as a rescue therapy in children and neonates for catecholamine-resistant shock.

Sascha Meyer, Sven Gottschling, Ludwig Gortner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431678     DOI: 10.1007/s00431-007-0481-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.

Authors:  Evelyn Lechner; Anna Hofer; Rudolf Mair; Werner Moosbauer; Eva Sames-Dolzer; Gerald Tulzer
Journal:  Eur J Pediatr       Date:  2007-01-16       Impact factor: 3.183

2.  Vasopressin in the treatment of vasodilatory shock in children.

Authors:  Satoshi Masutani; Hideaki Senzaki; Hirotaka Ishido; Mio Taketazu; Tamotsu Matsunaga; Toshiki Kobayashi; Nozomu Sasaki; Haruhiko Asano; Shunei Kyo; Yuji Yokote
Journal:  Pediatr Int       Date:  2005-04       Impact factor: 1.524

3.  Vasopressin deficiency contributes to the vasodilation of septic shock.

Authors:  D W Landry; H R Levin; E M Gallant; R C Ashton; S Seo; D D'Alessandro; M C Oz; J A Oliver
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

4.  Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature.

Authors:  Jennifer L Liedel; William Meadow; James Nachman; Tracy Koogler; Madelyn D Kahana
Journal:  Pediatr Crit Care Med       Date:  2002-01       Impact factor: 3.624

5.  Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury.

Authors:  Sascha Meyer; Sven Gottschling; Ali Baghai; Donald Wurm; Ludwig Gortner
Journal:  Crit Care       Date:  2006-05-05       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.